Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heideman

Showing results (91-100 of 272) with videos related to

Pageof 28
Sort By:
Journal of Clinical Pathology|February 10, 2015
Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitorJustine L Kuiper, Merle I Ronden, Annemarie Becker, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 25, 2008
Vaccination against HPV: indications for women and the impact on the cervical screening programmeD A M Heideman, P J F Snijders, J Berkhof, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responsesBianca van Veggel, Adrianus J de Langen, Sayed Hashemi, et al.
Journal of Clinical Microbiology|January 1, 2010
Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screeningA T Hesselink, D A M Heideman, J Berkhof, et al.
Oncotarget|October 27, 2017
Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in BhutanUgyen Tshomo, Silvia Franceschi, Tshokey Tshokey, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 12, 2015
Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive womenRoosmarijn Luttmer, Johannes Berkhof, Maaike G Dijkstra, et al.
Journal of Clinical Microbiology|October 13, 2017
Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 PanelN J Polman, A Oštrbenk, L Xu, et al.
The Lancet. Global Health|May 19, 2023
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveysFelix Sayinzoga, Vanessa Tenet, Daniëlle A M Heideman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 21, 2019
Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panelD A M Heideman, L Xu, A T Hesselink, et al.
The Journal of Molecular Diagnostics : JMD|April 7, 2018
Added Value of 50-Gene Panel Sequencing to Distinguish Multiple Primary Lung Cancers from Pulmonary Metastases: A Systematic InvestigationPaul Roepman, Alexandra Ten Heuvel, Karen C Scheidel, et al.
Pageof 28

Showing results (91-100 of 272) with videos related to

Sort By:
Pageof 28
Journal of Clinical Pathology|February 10, 2015
Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitorJustine L Kuiper, Merle I Ronden, Annemarie Becker, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|July 25, 2008
Vaccination against HPV: indications for women and the impact on the cervical screening programmeD A M Heideman, P J F Snijders, J Berkhof, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
Crizotinib treatment for patients with EGFR mutation positive NSCLC that acquire cMET amplification after EGFR TKI therapy results in short-lived and heterogeneous responsesBianca van Veggel, Adrianus J de Langen, Sayed Hashemi, et al.
Journal of Clinical Microbiology|January 1, 2010
Comparison of the clinical performance of PapilloCheck human papillomavirus detection with that of the GP5+/6+-PCR-enzyme immunoassay in population-based cervical screeningA T Hesselink, D A M Heideman, J Berkhof, et al.
Oncotarget|October 27, 2017
Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in BhutanUgyen Tshomo, Silvia Franceschi, Tshokey Tshokey, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 12, 2015
Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive womenRoosmarijn Luttmer, Johannes Berkhof, Maaike G Dijkstra, et al.
Journal of Clinical Microbiology|October 13, 2017
Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 PanelN J Polman, A Oštrbenk, L Xu, et al.
The Lancet. Global Health|May 19, 2023
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveysFelix Sayinzoga, Vanessa Tenet, Daniëlle A M Heideman, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 21, 2019
Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panelD A M Heideman, L Xu, A T Hesselink, et al.
The Journal of Molecular Diagnostics : JMD|April 7, 2018
Added Value of 50-Gene Panel Sequencing to Distinguish Multiple Primary Lung Cancers from Pulmonary Metastases: A Systematic InvestigationPaul Roepman, Alexandra Ten Heuvel, Karen C Scheidel, et al.
Pageof 28